Butyrophenone
Appearance
| |||
Names | |||
---|---|---|---|
IUPAC name
1-phenylbutan-1-one
| |||
Identifiers | |||
3D model (JSmol)
|
|||
ChEMBL | |||
ChemSpider | |||
ECHA InfoCard | 100.007.091 | ||
PubChem CID
|
|||
UNII | |||
CompTox Dashboard (EPA)
|
|||
| |||
| |||
Properties | |||
C10H12O | |||
Molar mass | 148.20 g/mol | ||
Appearance | clear liquid | ||
Melting point | 12 °C (54 °F; 285 K) | ||
Boiling point | 229 °C (444 °F; 502 K) | ||
poor | |||
log P | 2.77 | ||
Refractive index (nD)
|
1.520 | ||
Hazards | |||
NFPA 704 (fire diamond) | |||
Flash point | 99 °C (210 °F; 372 K) | ||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Butyrophenone is a chemical compound; some of its derivatives (called commonly butyrophenones) are used to treat various psychiatric disorders such as schizophrenia, as well as acting as antiemetics.[1]
Examples of butyrophenone-derived pharmaceuticals include:
- Haloperidol, the most widely used classical antipsychotic drug in this class[1]
- Benperidol, the most potent commonly used antipsychotic (200 times more potent than chlorpromazine)[1][2]
- Droperidol, Antiemetic for postoperative nausea and vomiting
References
- ^ a b c Keith Parker; Laurence Brunton Goodman; Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11th ed.). New York: McGraw-Hill. ISBN 0071422803.
- ^ Grogan, Charles H.; Rice, Leonard M. (1967). "Ω-Azabicyclic Butyrophenones". Journal of Medicinal Chemistry. 10 (4): 621. doi:10.1021/jm00316a022. PMID 6037051.